-
The successor of the blockbuster diet drug Somaglutide
On July 27, 2023, Lilly announced that the Mount-3 study of Tirzepatide for treating obese patients and the Mount-4 study for maintaining weight loss of obese patients had reached the primary end point and the key secondary end point. This is the third and fourth success...Read more -
Characteristics of polypeptide
Peptide is an organic compound, which is dehydrated from amino acids and contains carboxyl and amino groups. It is an amphoteric compound. Polypeptide is a compound formed by amino acids linked together by peptide bonds. It is an intermediate product of protein ...Read more -
CagriSema’s clinical acceleration of weight loss in China
On July 5, Novo Nordisk launched a phase III clinical trial of CagriSema injection in China, the purpose of which is to compare the safety and efficacy of CagriSema injection with semeglutide in obese and overweight patients in China. CagriSema injection is a long-acting...Read more
